Bryan, Garnier & Co acts as Sole Financial Advisor to PhysioAssist on its $45m Sale to Inogen

Healthcare

Bryan, Garnier & Co acts as Sole Financial Advisor to PhysioAssist on its $45m Sale to Inogen

PhysioAssist is a medical device company which develops and manufactures Simeox, a disruptive airway clearance technology.

Simeox is intended for patients suffering from obstructive chronic lung diseases such as Bronchiectasis, COPD and Cystic Fibrosis.

This technology is CE-marked and sold in more than 20 countries worldwide in Europe, Asia, and the Middle East through a network of distributors. PhysioAssist is currently seeking FDA clearance to tackle the US market.

Bryan, Garnier & Co acted as Sole Financial Advisor to PhysioAssist and its shareholders.

The team ran a competitive dual track process (Private Placement / M&A), introducing and guiding both respiratory care sector corporates as well as healthcare specialists VC / PE, to identify the best partner for PhysioAssist to accelerate its growth and support its US ambitions.

As a result of the absolute commitment of its team in a challenging environment, Bryan Garnier & Co delivered on all objectives, identifying the most synergistic partner, Inogen, to enable Simeox to reach maximum potential improving patients’ lives worldwide.

This transaction is a testimony of Bryan, Garnier & Co’s expertise in the medtech sector and ability to deliver a swift cross-border deal for its clients.

"We are thrilled to have successfully achieved our fundraising target enabling us to build and operate the world's first PET biorecycling plant and extend the benefits of our technology to all types of plastics. As our trusted advisor, Bryan Garnier's team expertise, efforts, and guidance throughout the process have been instrumental."

— Emmanuel Ladent - CEO of Carbios

Founded in 2012 PhysioAssist is a company at the crossroads of three major technological fields: physics of materials, signal processing and life sciences. Since inception, PhysioAssist has worked for improving the quality of life of patients. The use and ergonomics of the company’s devices have been optimized and studied to be suitable for the daily care provided to patients by healthcare professionals. PhysioAssist offers today solutions for an efficient treatment in airway clearance.

Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.